In addition, Didemethoxylated curcumin may increase the sensitivity of cisplatin-resistant lung cancer cells to chemotherapy by inhibiting CA916798 (an over-expressed MDR protein) and PI3K/AKT/mTOR signaling, thus exerting antitumor activity and reversing MDR [196]. Here, AKT1 is linked to lung carcinoma.